Form 4 for ATYR aTYR PHARMA INC
Accepted 2023-04-28 00:00:00 ET · period of report 2023-04-26 · accession 0001209191-23-026067 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-04-28 | 2023-04-26 | ATYR | SCHIMMEL PAUL | Dir | M - OptEx | — | +6,000 | 8,890 | +208% | — |
| D | 2023-04-28 | 2023-04-26 | ATYR | SCHIMMEL PAUL | Dir | M - OptEx | $0.00 | -6,000 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock | 2023-04-26 | M | A | 6,000 | — | 8,890 | D | — | — | (F2) RSUs convert into common stock on a one-for-one basis. |
| 2 | Derivative | Restricted Stock Unit | 2023-04-26 | M | D | 6,000 | $0.00 | 0 | D | — · — to — | 6,000 Common Stock | (F2) RSUs convert into common stock on a one-for-one basis. (F5) The RSUs fully vested one year from the grant date which was April 26, 2022. |